CD47 and impulse control disorder: Several strategies have also been focused on overcoming ICD deficiencies such as intratumoral injection of pattern recognition receptor (PRR) agonists or recombinant type I IFNs64, 65, 66 or the inhibition of endogenous suppressors of adaptive immunity elicited by ICD, including CD47 blocking with specific monoclonal antibodies67.